Published in TB and Outbreaks Week, February 17th, 2004
The announcement came from Founder and CEO Victoria Hale, PhD. Hale was invited to speak at the World Economic Forum in Davos, Switzerland, as a panelist in a roundtable discussion, "Winning the All-Fronts War against AIDS." While at the international meeting, Hale announced OneWorld Health's intention to bring paromomycin to market in India in the next year.
Paromomycin is a treatment for visceral leishmaniasis (VL), also known as kala azar....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week